Buccal transmucosal delivery of calcitonin in rabbits using thin-film composites

Pharmaceutical Research

Volumn 19, Issue 12, 2002, Pages 1901-1906

  Cui, Zhengrong ^a   Mumper, Russell J ^a  

^a University of Kentucky   (United States)

Author keywords

Calcium; Eudragit; Film; Mucoadhesive; Polycarbophil; Salmon calcitonin; Wax

Indexed keywords

ADHESIVE AGENT; CALCITONIN; CALCIUM; EUDRAGIT; POLYCARBOPHIL; SALCATONIN; WAX;

AEROSOL; ANIMAL EXPERIMENT; ARTICLE; CHEEK MUCOSA; DRUG DELIVERY SYSTEM; FEMALE; FILM; HYPERCALCEMIA; NONHUMAN; OSTEOPOROSIS; PAGET BONE DISEASE; PRIORITY JOURNAL; RABBIT;

ADMINISTRATION, BUCCAL; ANIMALS; BIOLOGICAL AVAILABILITY; CALCITONIN; CALCIUM; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; FEMALE; MOUTH MUCOSA; RABBITS;

EID: 0036913714     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021462012442     Document Type: Article

References (26)

1. L. E. Wehren. The role of the primary care physician in diagnosis and management of osteoporosis. Int. J. Fertil. Womens Med. 47:116-122 (2002).
2. M. Zaidi, A. M. Inzerillo, B. S. Moonga, P. J. R. Bevis, and C. L. H. Huang. Forty years of calcitonin-where are we now? A tribute to the work of Iain Macintyre, FRS. Bone 30:655-663 (2002).
3. J. R. Potts. Chemistry of calcitonin. Bone Mineal. 16:169-173 (1992).
4. D. J. Hosking and O. L. M. Bijvoet. Therapeutic uses of calcitonin. In J. A. Parsons (ed.), Endocrinology of Calcium Metabolism. Raven Press, New York, 1982 pp. 485-535.
5. L. J. Deftos. Calcitonin in clinical medicine. Adv. Intern. Med. 23:159-193 (1978).
6. M. Azria, D. H. Copp, and J. M. Zanelli. 25 Years of salmon calcitonin: From synthesis to therapeutic use. Calcif. Tissue Int. 57:407-408 (1995).
7. Mosby's Drug Consult Top 200. http://www.mosbydrugconsult.com/DrugConsult/Top_200/
8. J. Y. Reginster and P. Franchimon. Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection. Clin. Exp. Rheumatol. 3:155-157 (1985).
9. W. A. Lee, R. D. Ennis, J. P. Longenecker, and P. Bengtsson. The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer. Pharm. Res. 11:747-750 (1994).
10. K. Morimoto, J. Katsumata, T. Yabuta, and K. Iwanaga, M Kakemi, Y. Tabata, and Y. Ikada. Gelatin microspheres as a pulmonary delivery system: Evaluation of salmon calcitonin absorption. J. Pharm. Pharmacol. 52:611-617 (2000).
11. Y. H. Lee and P. J. Sinko. Oral delivery of salmon calcitonin. Adv. Drug Deliv. Rev. 42:225-238 (2000).
12. Y. Nakada, N. Awata, C. Nakamichi, and S. Goto. The effects of additives on the oral mucosal absorption of human calcitonin in rats. J. Pharmacobio-Dyn. 11:395-401 (1988).
13. S. J. Heiber, C. D. Ebert, S. C. Dave, K. Smith, S. W. Kim, and D. Mix. In-vivo buccal delivery of calcitonin. J. Control. Release 28:269-271 (1994).
14. H. H. Alur, J. D. Beal, S. I. Pather, A. K. Mitra, and T. P. Johnston. Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. J. Pharm. Sci. 88:1313-1319 (1999).
15. T. Ogiso, M. Iwaki, T. Tanino, and T. Paku. Effectiveness of the elcatonin transdermal system for the treatment of osteoporosis and the effect of the combination of elcatonin and active vitamin D3 in rat. Biol. Pharm. Bull. 16:895-898 (1993).
16. E. Bonucci, P. Ballanti, P. A. Ramires, J. L. Richardson, and L. M. Benedetii. Prevention of ovariectomy osteopenia in rats after vaginal administration of Hyaff 11 microspheres containing salmon calcitonin. Calcif. Tissue Int. 56:274-279 (1995).
17. M. Baluom, D. I. Friedman, and A. Rubinstein. Absorption of calcitonin in the rat intestine by carbopol-containing submicron emulsions. Int. J. Pharm. 154:235-243 (1997).
18. N. N. Aldini, P. Caliceti, S. Lora, M. Fini, G. Giavaresi, M. Rocca, P. Torricelli, R. Giardino, and F. M. Veronese. Calcitonin release system in the treatment of experimental osteoporosis: Histomorphometric evaluation. J. Orthop. Res. 19:955-961 (2001).
19. H. E. Junginger, J. A. Hoogstraate, and J. C. Verhoef. Recent advances in buccal drug delivery and absorption-in vitro and in vivo studies. J. Control. Release 62:149-159 (1999).
20. Z. Cui and R. J. Mumper. Bi-layer disks for mucosal (genetic) immunization via the buccal route in rabbits. AAPS PharmSci 3(3) (2001).
21. Z. Cui and R. J. Mumper. Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits. Pharm. Res. 19:947-953 (2002).
22. S. Jay, W. Fountain, Z. Cui, and R. J. Mumper. Transmucosal delivery of testosterone in rabbits using novel bi-layer mucoadhesive wax-film composite disks. J. Pharm. Sci. 91:2016-2024 (2002).
23. P. L. Ritger and N. A. Peppas. A simple equation for description of solute release II: Fickian and anomalous release from swellable devices. J. Control. Release 5:37-42 (1987).
24. P. J. Sinko, C. L. Smith, L. T. McWhorter, W. Stern, E. Wagner, and J. P. Gilligan. Utility of pharamacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats. J. Pharm. Sci. 84:1374-1378 (1995).
25. R. S. Langer and N. A. Peppas. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 2:201-213 (1981).
26. A. Wade and P. J. Weller. Handbook of Pharmaceutical Excipients, 2nd Ed., American Pharmaceutical Association, Washington, and The Pharmaceutical Press, London, 1994.